48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study

E. Martinez; L. Assoumou; G. Moyle; L. Waters; M. Johnson; P. Domingo; J. Fox; H. Stellbrink; G. Guaraldi; M. Masia; M. Gompels; S. de Wit; E. Florence; S. Esser; F. Raffi; A. Pozniak; J. Gatell

48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study

E. Martinez, L. Assoumou, G. Moyle, L. Waters, M. Johnson, P. Domingo, J. Fox, H. Stellbrink, G. Guaraldi, M. Masia, M. Gompels, S. de Wit, E. Florence, S. Esser, F. Raffi, A. Pozniak, J. Gatell

Research output: Contribution to journal › Conference abstract in journal

Original language	English
Journal	Journal of the International AIDS Society
Volume	21
Number of pages	2
ISSN	1758-2652
Publication status	Published - 2018

Keywords

DISEASE

Cite this

Martinez, E., Assoumou, L., Moyle, G., Waters, L., Johnson, M., Domingo, P., Fox, J., Stellbrink, H., Guaraldi, G., Masia, M., Gompels, M., de Wit, S., Florence, E., Esser, S., Raffi, F., Pozniak, A., & Gatell, J. (2018). 48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study. Journal of the International AIDS Society, 21.

@article{ca6998da5ce24908a8de87a227c8e291,

title = "48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study",

keywords = "DISEASE",

author = "E. Martinez and L. Assoumou and G. Moyle and L. Waters and M. Johnson and P. Domingo and J. Fox and H. Stellbrink and G. Guaraldi and M. Masia and M. Gompels and {de Wit}, S. and E. Florence and S. Esser and F. Raffi and A. Pozniak and J. Gatell",

note = "NFT",

year = "2018",

language = "English",

volume = "21",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "John Wiley & Sons",

}

Martinez, E, Assoumou, L, Moyle, G, Waters, L, Johnson, M, Domingo, P, Fox, J, Stellbrink, H, Guaraldi, G, Masia, M, Gompels, M, de Wit, S, Florence, E, Esser, S, Raffi, F, Pozniak, A & Gatell, J 2018, '48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study', Journal of the International AIDS Society, vol. 21.

TY - JOUR

T1 - 48-week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study

AU - Martinez, E.

AU - Assoumou, L.

AU - Moyle, G.

AU - Waters, L.

AU - Johnson, M.

AU - Domingo, P.

AU - Fox, J.

AU - Stellbrink, H.

AU - Guaraldi, G.

AU - Masia, M.

AU - Gompels, M.

AU - de Wit, S.

AU - Florence, E.

AU - Esser, S.

AU - Raffi, F.

AU - Pozniak, A.

AU - Gatell, J.

N1 - NFT

PY - 2018

Y1 - 2018

KW - DISEASE

M3 - Conference abstract in journal

SN - 1758-2652

VL - 21

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

ER -